TY - JOUR
T1 - Life in cellulose houses
T2 - Symbiotic bacterial biosynthesis of ascidian drugs and drug leads
AU - Schmidt, Eric W.
AU - Donia, Mohamed S.
N1 - Funding Information:
Our work on ascidians is funded by NIH (GM0171425).
PY - 2010/12
Y1 - 2010/12
N2 - Ascidians (tunicates; sea squirts) are sources of diverse, bioactive natural products, one of which is an approved drug and many of which are potent drug leads. It has been shown that symbiotic bacteria living with ascidians produce some of the bioactive compounds isolated from whole animals, and indirect evidence strongly implicates symbiotic bacteria in the synthesis of many others. However, for the majority the producing organism has not been identified. In cases where a symbiotic origin has been definitively assigned, the resulting data lead to improved paths to drug discovery and development from marine animals. This review traces evidence for symbiotic production where such evidence exists and describes the strengths and limitations of that evidence.
AB - Ascidians (tunicates; sea squirts) are sources of diverse, bioactive natural products, one of which is an approved drug and many of which are potent drug leads. It has been shown that symbiotic bacteria living with ascidians produce some of the bioactive compounds isolated from whole animals, and indirect evidence strongly implicates symbiotic bacteria in the synthesis of many others. However, for the majority the producing organism has not been identified. In cases where a symbiotic origin has been definitively assigned, the resulting data lead to improved paths to drug discovery and development from marine animals. This review traces evidence for symbiotic production where such evidence exists and describes the strengths and limitations of that evidence.
UR - http://www.scopus.com/inward/record.url?scp=78349310737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78349310737&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2010.10.006
DO - 10.1016/j.copbio.2010.10.006
M3 - Review article
C2 - 21050742
AN - SCOPUS:78349310737
SN - 0958-1669
VL - 21
SP - 827
EP - 833
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
IS - 6
ER -